Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionFca Corp /tx
Latest Disclosed Ownership18,432 shares
Latest Disclosed Value $ 6,485,160
Fca Corp /tx reports 2.08% increase in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Fca Corp /tx filed a 13F-HR form disclosing ownership of 18,432 shares of Amgen Inc. (MX:AMGN) valued at $6,485,160 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 18,056 shares of Amgen Inc.. This represents a change in shares of 2.08% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 18,432 376 2.08 6,485 9.75 1.7722
2026-02-11 2025-12-31 13F AMGEN COM 031162100 18,056 -659 -3.52 5,910 11.89 1.6683
2025-11-14 2025-09-30 13F AMGEN COM 031162100 18,715 479 2.63 5,281 3.73 1.4667
2025-08-12 2025-06-30 13F AMGEN COM 031162100 18,236 325 1.81 5,092 -8.76 1.5245
2025-05-13 2025-03-31 13F AMGEN COM 031162100 17,911 -429 -2.34 5,580 16.74 1.7792
2025-02-11 2024-12-31 13F AMGEN COM 031162100 18,340 149 0.82 4,780 -18.44 1.4926
2024-11-13 2024-09-30 13F AMGEN COM 031162100 18,191 222 1.24 5,861 4.40 1.7976
2024-08-13 2024-06-30 13F AMGEN COM 031162100 17,969 162 0.91 5,614 10.90 1.7966
2024-05-08 2024-03-31 13F AMGEN COM 031162100 17,807 165 0.94 5,063 -0.37 1.6377
2024-02-08 2023-12-31 13F AMGEN COM 031162100 17,642 21 0.12 5,081 7.31 1.7469
2023-11-13 2023-09-30 13F AMGEN COM 031162100 17,621 565 3.31 4,736 25.07 1.7659
2023-08-14 2023-06-30 13F AMGEN COM 031162100 17,056 -265 -1.53 3,787 -9.58 1.4045
2023-05-12 2023-03-31 13F AMGEN COM 031162100 17,321 1,634 10.42 4,187 1.63 1.5710
2023-02-14 2022-12-31 13F AMGEN COM 031162100 15,687 102 0.65 4,120 17.28 1.6566
2022-11-14 2022-09-30 13F AMGEN COM 031162100 15,585 115 0.74 3,513 -6.67 1.4918
2022-08-12 2022-06-30 13F AMGEN COM 031162100 15,470 -198 -1.26 3,764 -0.66 1.4830
2022-05-13 2022-03-31 13F AMGEN COM 031162100 15,668 80 0.51 3,789 8.04 1.3224
2022-02-14 2021-12-31 13F AMGEN COM 031162100 15,588 -2,100 -11.87 3,507 -6.75 1.1938
2021-11-12 2021-09-30 13F AMGEN COM 031162100 17,688 117 0.67 3,761 -12.19 1.1321
2021-08-13 2021-06-30 13F Amgen COM 031162100 17,571 -884 -4.79 4,283 -6.73 1.2129
2021-05-12 2021-03-31 13F Amgen COM 031162100 18,455 -73 -0.39 4,592 7.79 1.3424
2021-03-04 2020-12-31 13F/A-1 Amgen COM 031162100 18,528 861 4.87 4,260 -5.12 1.3658
2021-02-12 2020-12-31 13F Amgen COM 031162100 18,528 861 4,260 1,318,844.6178
2020-11-12 2020-09-30 13F Amgen COM 031162100 17,667 -794 -4.30 4,490 3.12 1.5414
2020-08-13 2020-06-30 13F Amgen COM 031162100 18,461 -5 -0.03 4,354 16.29 1.6594
2020-05-20 2020-03-31 13F/A-1 Amgen COM 031162100 18,466 773 4.37 3,744 -12.22 1.6388
2020-05-19 2020-03-31 13F Amgen COM 031162100 17,693 0 4,265 1,459,541.7757
2020-02-11 2019-12-31 13F Amgen COM 031162100 17,693 38 0.22 4,265 24.85 1.4797
2019-11-06 2019-09-30 13F Amgen COM 031162100 17,655 -835 -4.52 3,416 0.26 1.2729
2019-08-13 2019-06-30 13F Amgen COM 031162100 18,490 745 4.20 3,407 1.07 1.2471
2019-05-14 2019-03-31 13F Amgen COM 031162100 17,745 -105 -0.59 3,371 -2.99 1.3114
2019-03-29 2018-12-31 13F/A-1 Amgen COM 031162100 17,850 -96 -0.53 3,475 -6.59 1.5626
2019-02-14 2018-12-31 13F Amgen COM 031162100 17,850 -96 3,475
2018-10-22 2018-09-30 13F Amgen COM 031162100 17,946 -444 -2.41 3,720 9.57 1.4206
2018-08-10 2018-06-30 13F Amgen COM 031162100 18,390 -20 -0.11 3,395 8.16 1.3540
2018-05-14 2018-03-31 13F Amgen COM 031162100 18,410 -732 -3.82 3,139 -5.71 1.2860
2018-02-13 2017-12-31 13F Amgen COM 031162100 19,142 239 1.26 3,329 -5.53 1.3263
2017-11-09 2017-09-30 13F Amgen COM 031162100 18,903 587 3.20 3,524 11.70 1.4562
2017-08-04 2017-06-30 13F Amgen COM 031162100 18,316 229 1.27 3,155 6.30 1.3803
2017-05-08 2017-03-31 13F Amgen COM 031162100 18,087 343 1.93 2,968 14.42 1.3990
2017-02-09 2016-12-31 13F Amgen COM 031162100 17,744 284 1.63 2,594 -10.92 1.2907
2016-11-09 2016-09-30 13F Amgen COM 031162100 17,460 -114 -0.65 2,912 8.90 1.5068
2016-08-04 2016-06-30 13F Amgen COM 031162100 17,574 -628 -3.45 2,674 -2.02 1.3653
2016-05-13 2016-03-31 13F Amgen COM 031162100 18,202 118 0.65 2,729 -7.05 1.4494
2016-02-05 2015-12-31 13F Amgen COM 031162100 18,084 -748 -3.97 2,936 12.71 1.7044
2015-11-09 2015-09-30 13F Amgen COM 031162100 18,832 -577 -2.97 2,605 -12.58 1.5131
2015-08-11 2015-06-30 13F AMGEN COM 031162100 19,409 2,409 14.17 2,980 9.68 1.6454
2015-05-12 2015-03-31 13F AMGEN COM 031162100 17,000 -80 -0.47 2,717 -0.15 1.4694
2015-02-13 2014-12-31 13F AMGEN COM 031162100 17,080 -1,710 -9.10 2,721 3.11 1.5573
2014-11-17 2014-09-30 13F AMGEN COM 031162100 18,790 652 3.59 2,639 22.92 1.4736
2014-08-14 2014-06-30 13F/A-1 AMGEN COM 031162100 18,138 -748 2,147 1.1790
2014-09-08 2014-06-30 13F/A-2 AMGEN COM 031162100 18,138 -748 -3.96 2,147 -7.81 1.1790
2014-08-12 2014-06-30 13F AMGEN COM 031162100 18,138 1,874
2014-09-08 2014-03-31 13F/A-1 AMGEN COM 031162100 18,886 -1,175 -5.86 2,329 1.75 1.4217
2014-05-14 2014-03-31 13F AMGEN COM 031162100 18,886 2,329
2014-02-12 2013-12-31 13F AMGEN COM 031162100 20,061 -878 -4.19 2,289 -2.51 1.3241
2014-09-08 2013-09-30 13F/A-1 AMGEN COM 031162100 20,939 951 4.76 2,348 19.07 1.3955
2013-11-06 2013-09-30 13F AMGEN COM 031162100 20,939 2,348
2013-08-09 2013-06-30 13F AMGEN COM 031162100 19,988 19,988 1,972 1.2330
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.